Beijing launched the first Humanoid Robot Games on August 15, showcasing over 500 robots from 16 countries in various fields, highlighting China's push for top-tier robotics by 2027. The event emphasized advances in AI, with industry leaders seeing it as crucial for real-world application development, amid promising investment trends and strategic collaborations.

FluMist, an FDA-approved nasal spray flu vaccine, is now available for home use to boost accessibility amid a severe flu season. Despite insurance coverage and ease of access, public skepticism poses challenges.

New research reveals ancient humans transported stones over eight miles for tool-making 2.6 million years ago, suggesting advanced planning and resource management. Evidence from the Nyayanga site in Kenya shows tools crafted from materials sourced long distances away, challenging previous assumptions about early human behavior.

The NSF and NVIDIA are investing $152 million in the Open Multimodal AI Infrastructure to boost open-source AI for scientific research. Led by the Allen Institute for AI, the project promises groundbreaking tools for fields such as materials science and biology, aiming for the first open AI model release in 18 months.

Groundbreaking research has yielded the first 3D images and videos of human embryos implanting into a collagen-based uterine model, offering new insights into implantation mechanics. This could revolutionize fertility treatments by understanding the crucial role of mechanical forces and enzyme activity in embryo implantation, potentially reducing miscarriage rates.

MIT researchers have unveiled COMET, an AI model that accelerates RNA delivery by designing superior lipid nanoparticles, outperforming existing options in lab tests. Funded by ARPA-H, it aims to revolutionize RNA therapies, addressing diseases like obesity and diabetes by improving delivery efficiency and storage.

High-purity rare earth oxides have been successfully produced from Halleck Creek's allanite ore, potentially reducing U.S. dependence on imports. American Rare Earths is advancing its domestic supply chain efforts, with shares rising 4% on the ASX amid progress toward commercialization.

The AHA and ACC have unveiled new 2025 guidelines for managing high blood pressure, focusing on earlier intervention and personalized treatment to prevent major health issues. These guidelines emphasize lifestyle changes and proactive management, advocating for blood pressure control starting at 130/80 mm Hg with an aim to reduce cognitive risks and other complications.

Autonomous robots successfully completed a 21-day mission in a volcanic cave in Lanzarote, Spain, testing their ability to map subterranean lava tubes for potential extraterrestrial habitats. Despite technological hurdles like sensor interference, the study highlights the need for enhanced sensor fusion and adaptive algorithms to improve autonomous navigation for future space exploration.

A 12-year-old boy with RDEB has seen significant improvements in wound healing and quality of life from a stem cell infusion clinical trial. The treatment, showing promise in reducing symptoms and long-term risks, is now under consideration for regulatory approval.

The editorial criticizes Robert F. Kennedy Jr. for cutting $500 million in federal funding for mRNA vaccine research, warning it endangers public health and undermines epidemic preparedness. Experts highlight mRNA's crucial role in combating diseases and urge continued investment to avoid resurgence of deadly viruses.

Scientists identified a new whale species, Janjucetus dullardi, from a 25-million-year-old fossil found in Australia, revealing insights into early whale evolution. This tiny predator, part of the rare mammalodontid family, showcases unique features like sharp teeth and large eyes, aiding understanding of ancient marine ecosystems.

The University of South Dakota is moving its medical school to Sioux Falls to enhance clinical and research opportunities and strengthen ties with major health systems. This strategic relocation aims to address healthcare needs in South Dakota, with a new $150 million facility planned and significant support from state leaders and students.

A new review of 46 studies links prenatal acetaminophen use to increased risks of autism and ADHD in children. While causality isn't proven, experts urge careful use of the drug during pregnancy.

Novo Nordisk's Wegovy has gained FDA approval for treating MASH, a severe liver condition linked to obesity, marking the first GLP-1 receptor agonist approved for this use. The approval follows positive Phase 3 trial results, with Wegovy showing significant efficacy in resolving steatohepatitis in patients.

Celcuity Inc. reported promising Phase III trial results for gedatolisib, showing significant improvements in progression-free survival for advanced breast cancer. The company plans to file an NDA with the FDA in late 2025, supported by strategic partnerships and robust financial backing to drive future developments.

The UK's MHRA has approved Sanofi's teplizumab, the first immunotherapy for type 1 diabetes, to delay progression in patients aged 8 and older with stage 2 T1D. Already approved in the US, teplizumab's approval is seen as a significant advance in diabetes treatment, akin to insulin's impact a century ago, with calls for its availability on the NHS and early screening to maximize benefits.

A breakthrough in cancer research highlights lactylation, a process where lactate modifies proteins, significantly influencing tumor aggression and immune evasion, particularly in triple-negative breast cancer (TNBC). Targeting this pathway with existing and novel therapies could revolutionize treatment for resistant cancers, supported by promising preclinical results and ongoing clinical trials funded by Chinese grants.

Researchers at Weill Cornell Medicine have discovered that gut neurons produce adrenomedullin 2 (ADM2), crucial for regulating immune responses in inflammation. This finding could revolutionize treatments for inflammatory bowel disease by targeting neuro-immune interactions, potentially leading to new therapies that enhance intestinal repair.